Network Modeling in Knee Osteoarthritis
2 other identifiers
observational
200
1 country
1
Brief Summary
This project seeks to understand inter-individual differences in chronic musculoskeletal pain (cMSKP). Our long-term objective is to develop clinically-feasible decision tools that enable whole-person assessment and management of cMSKP and guide personalized primary, secondary and tertiary prevention strategies. Our secondary objective is to understand how inter-relationships between physiological, biomechanical and psychosocial factors change over time and impact the experience of living with chronic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 13, 2026
CompletedFirst Submitted
Initial submission to the registry
June 9, 2026
CompletedFirst Posted
Study publicly available on registry
August 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2029
August 5, 2026
June 1, 2026
3.4 years
June 9, 2026
July 31, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Symptom network
We will construct time varying networks for each patient based on longitudinal variables describing multiple domains: psychosocial, biomechanical and physiological. Change in network topology will be used as the primary outcome measure.
Every 3 months for one year
Secondary Outcomes (3)
WOMAC
Every 3 months for 1 year
WHOQOL
Every 3 months for 1 year
Allostatic load
Every 3 months for 1 year
Study Arms (1)
knee pain group
adults with chronic knee pain
Eligibility Criteria
Patients seeking physical therapy
You may qualify if:
- Adults aged 18-years old or more
- Chronic pain for 3 months or more around the knee joint.
You may not qualify if:
- Acute pain due to knee injury or surgery within the past 3 months.
- Diagnosis of lumbar radiculopathy, neuropathy or neuritis.
- Special populations i. Adults unable to consent ii. Pregnant women (self-reported) iii. Prisoners iv. George Mason University Athletes
- Military
- Bleeding disorders, blood thinners, recent blood transfusions, vasovagal syncope, and current infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Optimal Motion Physical Therapy
Herndon, Virginia, 20170, United States
Related Publications (4)
Liang Y, Booker C. Allostatic load and chronic pain: a prospective finding from the national survey of midlife development in the United States, 2004-2014. BMC Public Health. 2024 Feb 9;24(1):416. doi: 10.1186/s12889-024-17888-1.
PMID: 38336697BACKGROUNDBorsboom D, Deserno MK, Rhemtulla M, Epskamp S, Fried EI, McNally RJ, et al. Network analysis of multivariate data in psychological science. Nat Rev Methods Primer. 2021 Aug 19;1(1):1-18.
BACKGROUNDFillingim RB. Individual differences in pain: understanding the mosaic that makes pain personal. Pain. 2017 Apr;158 Suppl 1(Suppl 1):S11-S18. doi: 10.1097/j.pain.0000000000000775.
PMID: 27902569BACKGROUNDMcBeth J, Jones K. Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol. 2007 Jun;21(3):403-25. doi: 10.1016/j.berh.2007.03.003.
PMID: 17602991BACKGROUND
Biospecimen
Serum
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2026
First Posted
August 5, 2026
Study Start
March 13, 2026
Primary Completion (Estimated)
July 31, 2029
Study Completion (Estimated)
August 1, 2029
Last Updated
August 5, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- After publication of primary study results
Deidentified records including patient reported outcomes will be shared.